A Smart + Strong Site
Subscribe to:
POZ magazine

Back to home » Treatment News » Top Stories

Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


April 9, 2009

Leptin Reduces Belly Fat

HIV-positive men who were given an experimental version of the hormone leptin had a significant reduction in their belly fat after three months of treatment, according to a study published in the April issue of The Journal of Clinical Endocrinology & Metabolism.

Leptin helps the body regulate appetite and how it uses fat stores for energy. Both human and animal studies have found that abnormally low leptin levels can lead to unhealthy changes in cholesterol, triglycerides and insulin.

To determine whether increasing leptin levels using a manufactured version of the hormone might help normalize cholesterol, triglyceride and insulin levels, Kathleen Mulligan, PhD, from the University of California in San Francisco, and her colleagues enrolled eight HIV-positive men with low leptin levels. All of the men had triglyceride and low-density lipoprotein (LDL)—the bad cholesterol—levels that were too high. The men also had insulin resistance, which can ultimately lead to diabetes, belly fat accumulation and lipoatrophy. The men received twice daily injections of leptin, with doses based on their body weight.

Mulligan’s team found that leptin replacement significantly reduced LDL and triglyceride levels. It also increased the levels of high-density lipoprotein (HDL)—the good cholesterol—and lowered the men’s degree of insulin resistance.

Of particular note, leptin also decreased the men’s belly fat accumulation by 32 percent, without further decreasing fat in the limbs. This reduction exceeds decreases reported with other experimental therapies. For example, Serono’s growth hormone (Serostim) decreased belly fat accumulation by 21 to 24 percent, and its growth hormone promoter tesamorelin, expected to be approved later this year, decreases belly fat by 15 percent. Plus, Mulligan’s team reports, leptin improved the body’s ability to break down blood glucose, whereas tesamorelin does not.

The authors caution that this is a very small pilot study and that the treatment was not compared with a placebo, which will be critical to proving its efficacy and safety. Nevertheless, the results are sufficiently impressive, and further studies are being urged.

Search: leptin, hormone, fat metabolism, lipoatrophy, fat accumulation, diabetes, blood sugar, glucose, HDL, LDL, cholesterol, triglycerides, Kathleen Mulligan, belly, gut

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (5 total)

[Go to top]

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Conference Coverage
Health Services Directory
POZ Magazine
AIDSmeds on Twitter

Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014

7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013

more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.